4.4 Article Proceedings Paper

Hemiparetic gait and changes in functional performance due to OnabotulinumtoxinA injection to lower limb muscles

期刊

TOXICON
卷 107, 期 -, 页码 109-113

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.toxicon.2015.08.004

关键词

Gait analysis; Hemiparesis; OnabotulinumtoxinA; Spasticity

向作者/读者索取更多资源

Objective: To review gait alterations and evaluate the effects of OnabotulinumtoxinA on spatiotemporal walking parameters of patients with hemiparetic gait. Design: Retrospective pre- and post-intervention analysis. Setting: Gait analysis laboratory in a tertiary level rehabilitation hospital. Participants: 42 patients with hemiparesis. 19 males and 23 females, age 18-78 years were included. Intervention: Spatiotemporal parameters collected before and within 4-10 weeks after OnabotA injection to the ankle muscles. Data was recorded at self-selected velocity on a 12 m instrumented walkway. The most common muscles injected were medial and lateral gastrocnemius, soleus and tibialis posterior. Average total OnabotulinumtoxinA dose was 320 +/- 107 units. Main outcome: Spatiotemporal parameters of walking assessed before (T-0) and within 4-10 weeks post injection (T-1). Paired t-test was used to compare pre- and post-intervention data. A sequential Holm-Bonferroni procedure was used to adjust for multiple comparisons and minimize the risk of type I error. Statistical significance was set at p < 0.05. Results: Statistically significant increases were seen for walking velocity (20%) (T-0 = 0.40 +/- 0.26 m/s and T-1 = 0.48 +/- 0.29 m/s; p = 0.006), and increased cadence (T-0 = 63.48 +/- 23.93 steps/min, and T-1 = 70.88 +/- 23.65 steps/min; p = 0.006) following OnabotulinumtoxinA injections. Conclusion: This study demonstrates that injection of OnabotulinumtoxinA 320 units to ankle muscles selected with the aid of dynamic electromyography can significantly increase gait velocity and enhance functional ambulation in adults with hemiparesis due to upper motor neuron syndrome. (C) 2015 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rehabilitation

Efficacy of Early Inpatient Rehabilitation of Post-COVID-19 Survivors Single-Center Retrospective Analysis

Ning Cao, Jaclyn Barcikowski, Franklin Womble, Bianca Martinez, Yevgeniya Sergeyenko, Jacob H. Koffer, Michael Kwasniewski, Thomas Watanabe, Rui Xiao, Alberto Esquenazi

Summary: This study aimed to understand the demographic, clinical characteristics, and effectiveness of early inpatient rehabilitation of post-COVID survivors. A retrospective analysis of 100 patients admitted to a COVID rehabilitation unit was conducted, and the results showed that most patients achieved significant functional gains after inpatient rehabilitation, but some still required cognitive support at discharge.

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2023)

Article Rehabilitation

International Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi

Marjorie Salga, Laure Gatin, Thierry Deltombe, Thierry Gustin, Stefano Carda, Philippe Marque, Paul Winston, Rajiv Reebye, Theodore Wein, Alberto Esquenazi, Mary-Ann Keenan, Franco Molteni, Paolo Zerbinati, Alessandro Picelli, Flavia Coroian, Bertrand Coulet, Nadine Sturbois-Nachef, Christian Fontaine, Alain Yelnik, Bernard Parratte, Prakash Henry, Srikant Venkatakrishnan, Philippe Rigoard, Romain David, Philippe Denormandie, Alexis Schnitzler, Etienne Allart, Francois Genet

Summary: International recommendations for the management of spastic equinovarus foot deformity were established through the Delphi method. It is recommended to assess the impact of the deformity on functional activities and differentiate between muscle overactivity and soft tissue contractures. The treatment approach depends on the correctability of the deformity and the patient's ability to stand or walk. Preoperative assessment should involve interdisciplinary consultations to define personalized goals before surgery.

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2023)

Letter Clinical Neurology

Corrections required for Dressler and Johnson 2022

Alberto Esquenazi, Mark Elliott, Andreas Lysandropoulos

JOURNAL OF NEURAL TRANSMISSION (2022)

Article Multidisciplinary Sciences

An impairment-specific hip exoskeleton assistance for gait training in subjects with acquired brain injury: a feasibility study

Chiara Livolsi, Roberto Conti, Eleonora Guanziroli, Thor Fridriksson, Asgeir Alexandersson, Kristleifur Kristjansson, Alberto Esquenazi, Raffaele Molino Lova, Duane Romo, Francesco Giovacchini, Simona Crea, Franco Molteni, Nicola Vitiello

Summary: This study aimed to investigate the feasibility and potential effects of a novel assistive device for gait rehabilitation in patients with acquired brain injury. The results showed that short-term gait training with the assistive device significantly improved walking performance and knee kinematics in the participants.

SCIENTIFIC REPORTS (2022)

Article Pharmacology & Pharmacy

Video enhanced visual analysis of hemiparetic gait muscle selection: A pilot study

Alberto Esquenazi

Summary: This paper summarizes the use of video enhanced visual analysis (VEVA) as a muscle selection assistance method for abnormal foot postures in adults with upper motor neuron syndrome (UMNS) treated with botulinum neurotoxin (BoNT-A) in a real-world setting. The study found that VEVA, in addition to clinical evaluation, facilitated muscle identification and selection of ankle deformities for treatment with BoNT-A. The findings showed marked improvements in ankle Modified Ashworth Scale, Tardieu Scale, and Passive Range of Motion as indicators of pharmacological activity, as well as an increase in self-selected walking velocity as a marker of functional improvement.

TOXICON (2023)

Article Medicine, General & Internal

Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact

Alberto Esquenazi, Wolfgang H. Jost, Catherine C. Turkel, Theodore Wein, Rozalina Dimitrova

Summary: Upper and lower limb spasticity often occurs after a stroke or in patients with neurological disorders, causing difficulties in mobility and daily living. The use of onabotulinumtoxinA has significantly improved the quality of life for these patients. Challenges in the treatment process included determining the muscles to inject and assessing the effectiveness. Despite these challenges, clinical trials targeting post-stroke spasticity have shown significant improvements and gained approval.

MEDICINE (2023)

Article Clinical Neurology

Telerehabilitation Initiated Early in Post-Stroke Recovery: A Feasibility Study

Dylan Edwards, Sapna Kumar, Lorie Brinkman, Isabel Cardoso Ferreira, Alberto Esquenazi, Tiffany Nguyen, Michael Su, Stephanie Stein, Jaun May, Allison Hendrix, Casey Finley, Emily Howard, Steven C. Cramer

Summary: The study examines the feasibility, safety, and potential efficacy of a telerehabilitation program for stroke patients. The results show that intensive telerehabilitation therapy is feasible, safe, and may have positive effects on motor function improvement.

NEUROREHABILITATION AND NEURAL REPAIR (2023)

Meeting Abstract Clinical Neurology

A VIRTUAL REALITY PLATFORM TO FACILITATE TRAINING ON TREATMENT OF LOWER LIMB SPASTICITY WITH ONABOTULINUMTOXINA

Erin McGonigle, Sherry Downie, Alberto Esquenazi, Gerard E. Francisco, Monica Verduzco-Gutierrez, Kimberly Ifantides, Amin Boroujerdi, Adam Buser, Gaurang Patel, Nicholas Ketchum

MUSCLE & NERVE (2022)

Meeting Abstract Clinical Neurology

PATIENT AND CLINICIAN SATISFACTION WITH ONABOTULINUMTOXINA TREATMENT FOR POST-STROKE SPASTIC HEMIPARESIS IN PATIENTS FROM THE ADULT SPASTICITY INTERNATIONAL REGISTRY (ASPIRE) STUDY

G. Bavikatte, G. Francisco, A. Esquenazi, A. Baricich, T. Musacchio, R. Jukic, W. Jost

INTERNATIONAL JOURNAL OF STROKE (2022)

Meeting Abstract Pharmacology & Pharmacy

Real-World Treatment Utilization and Effectiveness of OnabotulinumtoxinA in Multiple Sclerosis Patients Treated for Spasticity From the ASPIRE Study

Daniel S. Bandari, Angeli Mayadev, Mohamed Sakel, Alberto Esquenazi, Aleksej Zuzek, Joan Largent, Gerard E. Francisco

TOXICON (2022)

Meeting Abstract Pharmacology & Pharmacy

Treatment of Patients With Upper Limb and Lower Limb Spasticity With OnabotulinumtoxinA in the Adult Spasticity International Registry (ASPIRE)

Ganesh Bavikatte, Gerard E. Francisco, Alberto Esquenazi, Michael A. Dimyan, Kenneth Ngo, Marc Schwartz, Aleks Zuzek, Wolfgang H. Jost

TOXICON (2022)

Meeting Abstract Pharmacology & Pharmacy

Dosing, Treatment Intervals, and Treatment Satisfaction With OnabotulinumtoxinA Over Time in the Adult Spasticity International Registry (ASPIRE)

Alberto Esquenazi, Wuwei Feng, George F. Wittenberg, Philippe Gallien, Alessio Baricich, Kristina Fanning, Aleksej Zuzek, Gerard E. Francisco, Daniel S. Bandari

TOXICON (2022)

Meeting Abstract Pharmacology & Pharmacy

Individualized OnabotulinumtoxinA Treatment of Upper Limb Spasticity in US Clinical Practices: Analysis of Practice Patterns From the ASPIRE Study

Gerard E. Francisco, Wayne Feng, Michael C. Munin, Kenneth Ngo, Marc Schwartz, Marjan Sadeghi, Aleks Zuzek, Alberto Esquenazi

TOXICON (2022)

Meeting Abstract Pharmacology & Pharmacy

A Virtual Reality Platform to Facilitate Training on Treatment of Lower Limb Spasticity With OnabotulinumtoxinA

Erin McGonigle, Sherry A. Downie, Alberto Esquenazi, Gerard E. Francisco, Monica Verduzco-Gutierrez, Kimberly Ifantides, Amin Boroujerdi, Adam Buser, Gaurang Patel, Nicholas Ketchum

TOXICON (2022)

Meeting Abstract Clinical Neurology

OnabotulinumtoxinA treatment and physician and patient satisfaction in patients with spastic hemiparesis from ASPIRE

G. Bavikatte, G. Francisco, A. Esquenazi, M. Schwartz, T. Musacchio, W. Jost

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Pharmacology & Pharmacy

Assessment of Aflatoxin M1 in human breast and powdered milk in Tehran, Iran

Mohammadhossein Movassaghghazani, Nazanin Shabansalmani

Summary: The study revealed high levels of AFM1 in both breast milk and powdered milk samples in Tehran, with some samples exceeding the established limits. Therefore, monitoring and regulating toxin levels in these products is crucial for maternal and infant health.

TOXICON (2024)

Article Pharmacology & Pharmacy

Integrating network pharmacology and experimental validation to explore the mechanisms of luteolin in alleviating fumonisin B1-induced intestinal inflammatory injury

Defeng Wen, Wantong Han, Quan Chen, Guanhui Qi, Mengling Gao, Pu Guo, Yu Liu, Zhongyuan Wu, Shulin Fu, Qirong Lu, Yinsheng Qiu

Summary: Luteolin can inhibit FB1-induced intestinal inflammatory injury by inhibiting the activation of NF-kappa B and ERK signaling pathways, according to network pharmacology and in vitro experiments.

TOXICON (2024)